| Primary |
| Dry Eye |
30.8% |
| Drug Use For Unknown Indication |
23.1% |
| Keratitis |
23.1% |
| Epilepsy |
7.7% |
| Hallucination |
7.7% |
| Product Used For Unknown Indication |
7.7% |
|
| Temporal Arteritis |
40.0% |
| Optic Neuritis |
20.0% |
| Respiratory Tract Infection |
20.0% |
| Skin Irritation |
20.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
36.4% |
| Dry Eye |
36.4% |
| Keratitis |
27.3% |
|
| Optic Neuritis |
50.0% |
| Temporal Arteritis |
50.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.3% |
| Drug Use For Unknown Indication |
23.8% |
| Pain |
3.4% |
| Hypertension |
3.1% |
| Dry Eye |
2.9% |
| Rheumatoid Arthritis |
2.3% |
| Pharyngitis Streptococcal |
2.2% |
| Pyrexia |
1.5% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hepatitis C |
1.4% |
| Eczema |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Prophylaxis |
1.0% |
| Anxiety |
0.9% |
| Infection |
0.9% |
| Depression |
0.8% |
| Angina Pectoris |
0.7% |
| Atrial Fibrillation |
0.7% |
| Body Temperature Increased |
0.6% |
| Constipation |
0.6% |
|
| Toxic Epidermal Necrolysis |
19.8% |
| Weight Decreased |
9.4% |
| Vision Blurred |
8.3% |
| Tendon Pain |
7.3% |
| Miosis |
6.3% |
| Pernicious Anaemia |
5.2% |
| Vomiting |
5.2% |
| Dry Eye |
4.2% |
| Electrocardiogram Qt Prolonged |
4.2% |
| Fatigue |
4.2% |
| Swelling Face |
4.2% |
| International Normalised Ratio Increased |
3.1% |
| Pemphigoid |
3.1% |
| Syncope |
3.1% |
| Chest Pain |
2.1% |
| Cholecystitis |
2.1% |
| Erythema Nodosum |
2.1% |
| Hospitalisation |
2.1% |
| Humerus Fracture |
2.1% |
| Lethargy |
2.1% |
|
